Your Messages Inbox
Your Article Summary
See Latest ArticlesServier Singled Out for New EU Antitrust Investigation
PharmExec, 07/16/09
As well as the reprimands and warnings from the European Commission's much anticipated report on its Big Pharma antitrust investigations on Wednesday was the announcement that the EC is launching a new investigation into Servier. The regulators are accusing the private-held French company of hindering the launch of generic versions of its heart disease drug, perindopril, saying they suspect that the company did deals with generic rivals Krka, Lupin, Matrix, Niche Generics Ltd and Teva to hold back cheaper versions.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
Shire, 11/30/09
Tricare contracts may be re-bid after losing plans protest
American Medical News , 11/25/09
GSK Regulatory Update: Avodart
GlaxoSmithKline, 11/24/09
Article Search
Sponsor